Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genta completes NDA submission for Genasense for malignant melanoma

Dec. 12, 2003

New preclinical and phase I data presented for CYC-202

Dec. 12, 2003

Grant supports matriptase inhibitor development at Curacyte

Dec. 12, 2003

Schering AG researchers claim new PLK inhibitors for cancer and other uses

Dec. 12, 2003

Palifermin improves quality of life in cancer patients with oral mucositis

Dec. 12, 2003

New PARP inhibitors described by KuDOS and Maybridge scientists

Dec. 12, 2003

BMS-247550 in metastatic breast cancer

Dec. 12, 2003

Safety and clinical efficacy of GW-572016 in advanced breast cancer

Dec. 12, 2003

Disease stabilization in phase II multiple myeloma study of Panzem

Dec. 12, 2003

Vion enters research and option agreement for novel anticancer compounds

Dec. 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...